NCT00042718View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.

PHASE3CompletedINTERVENTIONAL

Enrollment

659

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

August 31, 2003

Conditions

BronchitisChronic Bronchitis

Interventions

DRUG

levofloxacin, azithromycin, amoxicillin/clavulanate

All Listed Sponsors

collaborator

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00042718 - A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis. | Biotech Hunter | Biotech Hunter